Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. issued a clarification confirming that holders of its H Shares must lodge transfer documents with the Company’s H-share registrar by 4:30 p.m. on Wednesday, 20 May 2026 in order to qualify for attendance and voting rights at the upcoming Annual General Meeting (AGM).

The updated cut-off supersedes the timing previously stated on page 9 and page AGM-4 of the circular dated 29 April 2026 as well as page 4 of the AGM notice. All remaining information in both documents remains unchanged.

Board composition at the date of the announcement is as follows: • Executive Directors: Zhao Da Jun (Chairman), Xue Yan • Non-executive Directors: Shen Bo, Yu Xiao Yang • Independent Non-executive Directors: Wang Hong Guang, Lam Siu Wing, Xu Pei Long • Employee Director: Qu Ya Nan

The clarification is intended to ensure shareholders adhere to the correct administrative deadline for AGM participation.